Brief: Praxis Precision Medicines To Host Conference Call To Announce Topline Results From The Radiant Trial And Provide Second Quarter 2025 Financial Results
29/07/2025 14:39
July 29 (Reuters) - Praxis Precision Medicines Inc PRAX.O: PRAXIS PRECISION MEDICINES TO HOST CONFERENCE CALL TO ANNOUNCE TOPLINE RESULTS FROM THE RADIANT TRIAL AND PROVIDE SECOND QUARTER 2025 FINANCIAL RESULTS Source text: ID:nGNX9T1CSy Further company coverage: PRAX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Praxis Precision Medicines
See all newsUS RESEARCH ROUNDUP-Arxis, Cigna, Vylor
Brief: Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Praxis Precision Medicines, Inc. reports results for the quarter ended June 30 - Earnings Summary
Praxis Precision Q2 net loss widens on higher expenses
Brief: Praxis Precision Q2 EPS USD -2.87